Media-OutReach Newswire 2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies
Media-OutReach Newswire Intermittent Hypoxia-Hyperoxia Therapy (IHHT) Launched: Breakthrough Breathing Therapy for Heart, Brain, and Healthy Aging
Media-OutReach Newswire CK Life Sciences’ Investigational Cancer Vaccines Deliver Promising Results - New Preclinical Study Data to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Media-OutReach Newswire Vinmec Recognized As Vietnam’s First Allergy & Clinical Immunology Center of Excellence
Media-OutReach Newswire Vinmec becomes the first Vietnamese healthcare system honoured with two accolades at the Healthcare Asia Awards 2025
Media-OutReach Newswire Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore
Media-OutReach Newswire Galaxy Macau Presents Luxurious Celebration of Renewal at Banyan Tree Macau with Michelin-starred Chef and Bartender from Asia’s 50 Best Bars
Media-OutReach Newswire Revolutionary Treatment Introduced in Hong Kong to Combat 2.4-Year Diagnosis Delay and Emotional Struggles in Vitiligo Patients
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire New Book Challenges Traditional Hypertension Treatments: Case Study Reveals Breakthrough Approach
Media-OutReach Newswire Dusit Thani Kyoto named Four-Star Hotel in Forbes Travel Guide’s 2025 Star Awards
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 5.